Skip to main content

The Zohydro Controversy: Modern Day (Part II)





In modern day pain medicine, many of the same historic controversies exist.


Addiction is a prevalent problem in society; sometimes it emerges when a patient is ordered pain medication for a legitimate purpose, only to fall victim to a bigger problem  Other times, people who are somehow predisposed to substance abuse find themselves drawn to it for recreation purposes.  In either case, once addicted, the problem is the same for all of these individuals.

Modern addiction medicine does not employ withdrawal or detoxification as part of treatment; it seems more common to send these persons to day programs or inpatient treatment and prescribe suboxone or some similar agent for maintenance purposes. My biggest problem with this approach is that the problem is not really fixed--it's only patched. You see, suboxone and its nearest relatives merely trick the body's opiate receptors into thinking that all is well.

In my work career, I witnessed this problem many times over.  The saddest situations were those where young pregnant women, once addicts, went through rehab only to emerge on one of these maintenance drugs. When their children came into the world, they were born addicted. There were other patients on high dose chronic pain medications or maintenance medication such as suboxone or methadone. At times, pain management was very difficult for these persons.

The FDA's latest efforts with regard to pain medications involves something they call REMS strategy.
This strategy aims to evaluate the risk of abuse potential before drugs with abuse potential are prescribed, and attempt to control the number of abusers in the population.  The success of this program remains to be seen.

Meanwhile, a new long acting opioid, Zohydro, has come onto the marketplace. Zohydro is the controlled release version of hydrocodone.  It was FDA approved in late 2013. While it seems that this product has great potential to help those with chronic pain, it sure has its share of critics. This stems from the fact that short acting products containing hydrocodone have high abuse potential. Why would Zohydro be any different?

In addition to regulations by the FDA, DEA, State Boards of Medicine, Dentistry, Pharmacy, etc. local governments are attempting chime in with their own regulations regarding opioids.  For instance, back in 2013, while Mayor Bloomberg was still in office--he set out to regulate the use of these medications in Emergency Rooms across NYC.   Similar rulings have been adopted in Washington State and Utah.
Now, with the latest drug--Zohydro--there is news of regulation in Massachusetts and hearings are underway in Pennsylvania.

Meanwhile, there are many stories about heroin usage on the rise.  It seems like the more things change, the more they stay the same. One has to wonder what the future holds for those who suffer from addiction and those who suffer from chronic pain.

Sources: FDA, Washington Times, Masslive, Fox43, Time,Pixabay






Sources: FDA,
Labels:

Comments

Post a Comment

Popular posts from this blog

Living with Chronic pain hits the big screen!

Been to the movies lately?  Jennifer Aniston is on the big screen in a recent release titled "Cake." Her character, Claire is a victim of chronic pain...she belongs to a support group, where all of the members are coming to terms with the suicide of one of their members.  Of course, she also takes pain medication and addiction is another of her problems...and of course there's more! I guess I am writing this post just to bring readers' attention to the fact that Hollywood has become aware of the crisis that is chronic pain.  This movie is a testament to that. People that don't have to live with this kind of pain don't fully understand the whole story.  Maybe this movie will shed some light on the issues. Here is the official trailer for the movie: Sources: prweb;NorthJersey.com;YouTube
Post a Comment
Read more

Effectiveness Of Ozone Injections Is No Longer Up In The Air

Most of us know someone who has osteoarthritis, if we don't have it ourselves.  Joint replacement surgery is a pretty common remedy when the joint becomes severely damaged and the patient is in a lot of pain.  With risk of complications from such a surgery, perhaps an alternative treatment should be tried first. One such remedy is the injection of a synthetic version of collagen(e.g. Synvisc®) into the affected joint.  This procedure restores the cushioning to a joint that has degenerated over the years. It can diminish the pain substantially and help put off joint replacement surgery for months to years.  The biggest drawback is that these products are expensive.   GoodRX , a web site that can be used to estimate the cost of medications, estimates the cost of these products to be over $1,000 each. Here's another example--and I am not sure how widely accepted this protocol has become since study authors introduced it in November 2015.  Are you r...
Post a Comment
Read more

Fibromyalgia Week: Day 2

Tender points...click caption for WebMD animation Tender points are a unique feature of fibromaylgia.  There are 18 such points on the human body (9 pairs as shown).  Using special technique by hand or a dolorimeter, a fibromyalgia patient will experience pain in at least 11 points, and there will be at least one painful tender point in each quadrant of the body! One study found that up to 96% of fibromyalgia patients suffer from sleep disorders. It is believed that this is responsible for a deprivation of delta sleep, during which human growth hormone is produced. This hormone is essential to tissue repair. Other common problems in fibromyalgia are fatigue, concentration/memory ("fibro fog"), and depression.  There is no doubt in my mind that just enabling the patient to sleep well on a regular basis would be of great benefit! It is not uncommon for fibromyalgia patients to have coexisting conditions--some of these are lupus, disease, irritable bowel syndrom...
Post a Comment
Read more